Teva Pharmaceutical Industries Reports - Industry Research

Europe Injectable Drug Delivery Devices Market

The Europe injectable drug delivery devices market is expected to register a CAGR of 10.5% over the forecast period, (2022-2027).

Acne Therapeutics Market

The Acne Therapeutics Market size is estimated at USD 8.64 billion in 2024, and is expected to reach USD 10.98 billion by 2029, growing at a CAGR of 4.89% during the forecast period (2024-2029).

Active Pharmaceutical Ingredients (API) Market

The Active Pharmaceutical Ingredients Market size is estimated at USD 216.5 billion in 2024, and is expected to reach USD 306.90 billion by 2029, growing at a CAGR of 7.22% during the forecast period (2024-2029).

Global Opioids Market

The Global Opioids Market size is estimated at USD 23.94 billion in 2024, and is expected to reach USD 28.78 billion by 2029, growing at a CAGR of 3.75% during the forecast period (2024-2029).

Paracetamol Market

The Paracetamol Market is expected to register a CAGR of 4.3% over the forecast period.

Transdermal Skin Patches Market

The Transdermal Skin Patches Market size is estimated at USD 8.92 billion in 2024, and is expected to reach USD 11.33 billion by 2029, growing at a CAGR of 4.87% during the forecast period (2024-2029).

Generic Drugs Market

The Generic Drugs Market size is estimated at USD 413.60 billion in 2024, and is expected to reach USD 508.79 billion by 2029, growing at a CAGR of 4.23% during the forecast period (2024-2029).

Contraceptive Pills Market

The contraceptive pills market is poised to register a CAGR of 9% during the forecast period.

Neurodegenerative Disease Market

The Neurodegenerative Disease Market size is estimated at USD 55.12 billion in 2024, and is expected to reach USD 77.82 billion by 2029, growing at a CAGR of 7.14% during the forecast period (2024-2029).

Spain Contraceptive Devices Market

The Spanish contraceptive device market is expected to register a 7.9% CAGR during the forecast period.

Dementia Drugs Market

The Dementia Drugs Market size is estimated at USD 16.44 billion in 2024, and is expected to reach USD 22.21 billion by 2029, growing at a CAGR of 6.20% during the forecast period (2024-2029).

Omeprazole and Antihistamine Market

The omeprazole and antihistamine market is expected to register a CAGR of 5.7% over the forecast period.

Oral Cancer Therapy Market

The Oral Cancer Therapy Market size is estimated at USD 2.05 billion in 2024, and is expected to reach USD 2.65 billion by 2028, growing at a CAGR of 5.32% during the forecast period (2024-2028).

Injectable Drug Delivery Devices Market

The Injectable Drug Delivery Devices Market size is estimated at USD 114.85 billion in 2024, and is expected to reach USD 162.15 billion by 2029, growing at a CAGR of 7.14% during the forecast period (2024-2029).

Global Polycystic Ovarian Syndrome Treatment Market

The polycystic ovarian syndrome (PCOS) treatment market is expected to register a growth rate of 5.2% over the forecast period., 2022-2027.

Benzodiazepine Drugs Market

The benzodiazepine drugs market studied was anticipated to grow with a CAGR of 2.4%, during the forecast period.

Neuropathic Pain Market

The neuropathic pain market studied is anticipated to register a CAGR of 5.5% during the forecast period.

Seasonal Affective Disorder Therapeutics Market

The seasonal affective disorder therapeutics market is expected to register a CAGR of 5.9% during the forecast period.

Global Bronchodilators Market

The bronchodilators market studied is expected to grow with an estimated CAGR of 4.7%, over the forecast period.

Global Specialty Pharmaceuticals Market

The specialty pharmaceuticals market is expected to grow at a significant CAGR of 35.4% during the study period (2022-2027).

Non-Hodgkin Lymphoma Therapeutics Market

The non-Hodgkin lymphoma therapeutics market is expected to register a CAGR of nearly 7.4% during the forecast period.

Africa Contraceptive Drugs and Devices Market

The African contraceptive drugs and devices market is expected to register a CAGR of 7.2% during the forecast period.

China Drug Delivery Devices Market

The China drug delivery devices market is expected to register a CAGR of 9.3% over the forecast period.

Global Cephalosporin Drugs Market

The cephalosporin drugs market is expected to grow at registering a CAGR of 2.75% during the forecast period (2022-2027).

North America Contraceptives Market

The number of unwanted pregnancies is found increasing in the North American region, and it is a matter of serious concern all around the world.

Female Contraceptive Market

The female contraceptive market is expected to register a CAGR of 8.5% during the forecast period.

Global Migraine Therapeutics Market

The Global Migraine Therapeutics Market size is estimated at USD 6.16 billion in 2024, and is expected to reach USD 8.58 billion by 2029, growing at a CAGR of 6.84% during the forecast period (2024-2029).

Non-opioid Pain Patch Market

The non-opioid pain patch market is expected to register a CAGR of 3.0% during the forecast period.

Global Aminoglycosides Market

The aminoglycosides market is expected to record a CAGR of 4.11% over the forecast period (2022-2027).

Global Auto-Injectors Market

The Global Auto-Injectors Market size is estimated at USD 10.84 billion in 2024, and is expected to reach USD 22.83 billion by 2029, growing at a CAGR of 16.05% during the forecast period (2024-2029).

Tourette Syndrome Treatment Market

The tourette syndrome (TS) treatment market is expected to register a CAGR of 10.4% over the forecast period.

Mild Traumatic Brain Injury Treatment Market

The Mild Traumatic Brain Injury Treatment market is expected to witness a CAGR of 3.8% during the forecast period.

Global Digital Dose Inhaler Market

The digital dose inhaler market is anticipated to grow with a CAGR of above 13.3% during the forecast period.

Glioblastoma Multiforme Treatment Market

The Glioblastoma Multiforme Treatment Market size is estimated at USD 2.80 billion in 2024, and is expected to reach USD 4.60 billion by 2029, growing at a CAGR of 8% during the forecast period (2024-2029).

Pseudomonas Aeruginosa Infection Treatment Market

The Pseudomonas aeruginosa infection treatment market is expected to register a CAGR of 4.7% during the forecast period.

Chronic Myelogenous Leukemia Treatment Market

The chronic myelogenous leukemia (CML) treatment market is expected to register a CAGR of 5.3% over the forecast period.

Pregabalin Market

The pregabalin market is projected toregister a CAGR of nearly 3% over the forecast period.

Global Narcolepsy Therapeutics Market

The narcolepsy therapeutics market is anticipated to witness a CAGR of 9.9% during the forecast period (2022-2027).

Primary Biliary Cholangitis (PBC) Therapeutics Market

The global primary biliary cholangitis (PBC) market is projected to grow with a CAGR of nearly 10% over the forecast period.

Herpes Simplex Virus Treatment Market

The Herpes Simplex Virus Treatment Market size is estimated at USD 2.48 billion in 2024, and is expected to reach USD 3.13 billion by 2029, growing at a CAGR of 4.77% during the forecast period (2024-2029).

Cyclosporine Drugs Market

The cyclosporine drugs market is expected to register a CAGR of 4.1% over the forecast period.

Imatinib Drug Market

The Imatinib Drug Market is expected to register a CAGR of 3% during the forecast period.

Capecitabine Market

The Capecitabine market studied was anticipated to grow with a CAGR of 5.5% during the forecast period owing to the rising demand for target drug therapy to decrease the possible side effects without affecting normal cells.

Global Tardive Dyskinesia Treatment Market

The Tardive Dyskinesia Treatment Market is expected to register a CAGR of 4.2% during the forecast period (2022-2027).

Sleep Disorders Treatment Market

The sleep disorders treatment market is anticipated to witness a CAGR of nearly 7.1% during the forecast period.

Sulphonamides Market

The sulphonamides market is anticipated to record a CAGR of nearly 4.1% over the forecast period.

Esomeprazole Market

The Esomeprazole Market is expected to register a CAGR of 5.2% over the forecast period.

Frontotemporal Disorders Treatment Market

The frontotemporal disorders treatment market is expected to register a CAGR of 7.2% during the forecast period.

High Potency APIs /HPAPI Market

The High Potency APIs /HPAPI Market size is estimated at USD 26.85 billion in 2024, and is expected to reach USD 41.83 billion by 2029, growing at a CAGR of 9.27% during the forecast period (2024-2029).

Global Specialty Injectable Generics Market

The specialty injectable generic market is projected to register a CAGR of 10.2% during the forecast period (2022-2027).

Global Lipid Regulators Market

The lipid regulators market is expected to register a CAGR of 5.1% over the forecast period.

Global Contraceptive Drugs and Devices Market

The contraceptive drugs and devices market is expected to register a CAGR of 7.92% during the forecast period.

United Kingdom Drug Delivery Devices Market

• The United Kingdom's drug delivery devices market is anticipated to register a CAGR of 22.81% during the forecast period.

Muscle Relaxant Drugs Market

The muscle relaxant drugs market is expected to register a CAGR of 5.6% over the forecast period.

Male Hypogonadism Market

The Male Hypogonadism Market is expected to register a CAGR of 5.1% during the forecast period.

Osteonecrosis Treatment Market

The osteonecrosis treatment market is expected to register a CAGR of 6.2% during the forecast period.

Cytomegalovirus Treatment Market

The Cytomegalovirus (CMV) Treatment Market is anticipated to register a CAGR of 6.1% during the forecast period.

Oxycodone Drugs Market

The oxycodone drugs market is expected to witness growth at a CAGR of 5.6% during the forecast period.

Cytotoxic Drugs Market

The global cytotoxic drugs market size is expected to register a CAGR of 1.2% over the forecast period.

Inhalation and Nasal Spray Generic Drugs Market

The inhalation and nasal spray generic drugs market is anticipated to register a CAGR of nearly 5.4% during the forecast period.

Hydroxyzine Imine Market

The hydroxyzine imine market is expected to grow at a significant CAGR of 5.1% during the forecast period.

Infectious Enteritis Treatment Market

The Infectious Enteritis Treatment market is anticipated to grow with a CAGR of nearly 4.9% during the forecast period.

Global Lenalidomide Market

The Lenalidomide market studied is expected to witness an estimated CAGR of 5.0% over the forecast period (2022-2027).

Global Endometriosis Treatment Market

The Endometriosis Treatment Market is expected to register a CAGR of 5.3% over the forecast period, 2022-2027.

Italy Drug Delivery Devices Market

The Italian drug delivery devices market is expected to register a CAGR of 22.4% over the forecast period.

France Drug Delivery Devices Market

The French drug delivery devices market is anticipated to expand at a CAGR of 5.2% over the forecast period.

Europe Biguanide Market

The Europe Biguanide Market size is estimated at USD 1.25 billion in 2024, and is expected to reach USD 1.33 billion by 2029, growing at a CAGR of 1.27% during the forecast period (2024-2029).

Middle East and Africa Biguanide Market

The Middle East and Africa Biguanide Market size is estimated at USD 311.96 million in 2024, and is expected to reach USD 370.86 million by 2029, growing at a CAGR of 3.52% during the forecast period (2024-2029).

Asia-Pacific Acute Myeloid Leukemia Treatment Market

The Asia-Pacific Acute Myeloid Leukemia Treatment Market size is estimated at USD 338.96 million in 2024, and is expected to reach USD 517.24 million by 2029, growing at a CAGR of 6.46% during the forecast period (2024-2029).

Hospital Infection Therapeutics Market

The hospital infection therapeutics market is expected to register a CAGR of 7.2% over the forecast period.

Montelukast Sodium Market

The Montelukast Sodium Market size is estimated at USD 4.08 billion in 2024, and is expected to reach USD 7.38 billion by 2029, growing at a CAGR of 12.60% during the forecast period (2024-2029).

Cardiac Arrhythmia Therapeutics Market

The Cardiac Arrhythmia Therapeutics Market is expected to register a CAGR of 4.3% during the forecast period.

Pneumonia Treatment Market

The pneumonia treatment market is expected to register a CAGR of 8.2% during the forecast period.

Human Reproductive Technologies Market

The global human reproductive technologies market is anticipated to grow with a CAGR of nearly 2% during the forecast period.

Hypogonadism Treatment Market

The Hypogonadism Treatment Market is expected to register a CAGR of 3% during the forecast period attributing to increase in the incidence of hypogonadism, a rise in awareness about the disease and its treatment options and growth of infertility rate.

Trachoma Treatment Market

During the time frame of the forecast, the trachoma treatment market is expected to grow at a CAGR of 5.5%.

Cough Hypersensitivity Syndrome Treatment Market

The cough hypersensitivity syndrome treatment market is expected to register a CAGR of 5.5% over the forecast period.

Hydroxychloroquine Drugs Market

The global hydroxychloroquine drugs market studied was anticipated to register a CAGR of nearly 16.8% during the forecast period.

Huntington's Disease Treatment Market

Huntington's disease treatment market is projected to register a CAGR of 21% during the forecast period.

Global Neuroprotective Agents Market

The Neuroprotective Agents Market is projected to register a CAGR of 6.70% during the forecast period (2022-2027).

Global Hypersomnia Treatment Market

The Hypersomnia Treatment market is projected to register a CAGR of 8.7% during the forecast period (2022 - 2027).

Cerebral Palsy Treatment Market

The cerebral palsy treatment market is expected to register a significant CAGR of 4.4% during the study period.

Chemotherapy-Induced Neutropenia (CIN) Treatment Market

The chemotherapy-induced neutropenia (CIN) treatment size is estimated at USD XX million in 2023.

Global Dyspnea Treatment Market

Dyspnea Treatment Market is expected to grow at a registered CAGR of 4.5% during the forecast period.

United States Active Pharmaceutical Ingredients (API) Market

The United States Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 9.5% over the forecast period.

United Kingdom Active Pharmaceutical Ingredients (API) Market

The United Kingdom Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 6.3% over the forecast period.

Germany Active Pharmaceutical Ingredients (API) Market

The German Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 6% over the forecast period.

India Active Pharmaceutical Ingredients (API) Market

The India Active Pharmaceutical Ingredients Market size is estimated at USD 13.64 billion in 2024, and is expected to reach USD 20.32 billion by 2029, growing at a CAGR of 8.31% during the forecast period (2024-2029).

Epinephrine Autoinjector Market

The epinephrine autoinjector market is expected to register a CAGR of 8.5% over the forecast period.